TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. Cash on Hand 2020–2025
TScan Therapeutics Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- TScan Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 152.4M, a 14.71% decrease year-over-year.
- TScan Therapeutics Inc. cash on hand for 2025 were 152.4M, a 14.71% decrease from 2024.
- TScan Therapeutics Inc. cash on hand for 2024 were 178.7M, a 33.99% increase from 2023.
- TScan Therapeutics Inc. cash on hand for 2023 were 133.4M, a 11.11% increase from 2022.
- TScan Therapeutics Inc. cash on hand for 2022 were 120.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| TScan Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $152 |
| 2024 | $179 |
| 2023 | $133 |
| 2022 | $120 |
| 2021 | $161 |
| 2020 | $35 |
| TScan Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $152 |
| 2024-12-31 | $179 |
| 2023-12-31 | $133 |
| 2022-12-31 | $120 |
| 2021-12-31 | $161 |
| 2020-12-31 | $35 |
TScan Therapeutics Inc. Cash on Hand — FAQ
TScan Therapeutics Inc. (TCRX) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRX's cash on hand history?
The chart and table above show TScan Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.